Siemens Healthineers to Invest €160 million for Innovation Hub in Bengaluru, India

By Sharada Prahladrao

Company and Product News

Siemens Healthineers has announced plans to invest €160 million (Rs 1,300 crore) over the next five  years in an innovation hub in Bengaluru, India.  The innovation hub will be housed in a new campus that combines innovation hubthe existing R&D center and an ultra-modern medical imaging factory.  The company plans to add up to 1,800 personnel in the next 10 years.

The investment is part of Siemens Healthineers’ “Strategy 2025.”  So far, the company has already invested about €300 million (Rs 2,500 crore) in R&D in the country.  With about 50 percent of all the software engineers in Siemens Healthineers, the existing R&D center at Bengaluru plays a strategic role in developing software products and platforms for imaging, diagnostics and advanced therapies.

The Bengaluru campus will be one of the four innovation hubs of the company, with other hubs located in USA, Germany, and China.  The Bengaluru hub will include centers of competence in digital technologies, such as data analytics, artificial intelligence, immersive technologies, like augmented and virtual reality, user experience, and cybersecurity.

According to Siemens Healthineers, Bengaluru is an ideal location for an innovation hub because of its strong innovation and healthcare ecosystems, coupled with reputed educational institutions.  The city offers a large talent pool who embrace digital with an open mindset and readily adapt to new ways of working with new-age technology competences.

The investment aims to make India a manufacturing center for the company’s products for emerging markets.  Today, the Bengaluru factory manufactures Cios Fit C-arms and Somatom.go CT scanners.  These entry-level systems are designed, developed and made in India, and are sold in South-East Asia, Africa, Eastern Europe, and South America.  Siemens Healthineers plans to expand its product portfolio to address the challenge of affordability that is specific to these markets.


Engage with ARC Advisory Group